Consulte los riesgos y beneficios de PREVNAR 13®. Completar las 4 dosis puede ayudar a proteger a su bebé de la ENI.
http://www.prevnar13espanol.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Friday
LOAD TIME
0.8 seconds
16x16
Pfizer Inc. (NYHQ)
Domain Registrations
235 E●●●●● St ,
New●●●ork , NY, 10017-5755
US
View this contact
Pfizer Inc. (NYHQ)
Domain Registrations
235 E●●●●● St ,
New●●●ork , NY, 10017-5755
US
View this contact
Pfizer Inc. (NYHQ)
Domain Registrations
235 E●●●●● St ,
New●●●ork , NY, 10017-5755
US
View this contact
BUY YOUR DOMAIN
14
YEARS
9
MONTHS
11
DAYS
MARKMONITOR INC.
WHOIS : whois.markmonitor.com
REFERRED : http://www.markmonitor.com
PAGES IN
THIS WEBSITE
1
SSL
EXTERNAL LINKS
32
SITE IP
107.21.203.117
LOAD TIME
0.766 sec
SCORE
6.2
Información sobre la ENI | PREVNAR 13® (vacuna antineumocócica conjugada 13 valente [proteína diftérica CRM197]) | Información de seguridad | prevnar13espanol.com Reviews
https://prevnar13espanol.com
Consulte los riesgos y beneficios de PREVNAR 13®. Completar las 4 dosis puede ayudar a proteger a su bebé de la ENI.
prevnar13espanol.com
Sitemap | Pfizer
https://www.prevnar13espanol.com/Sitemap
Skip directly to content. Sorry this website is currently under maintenance. This website is unavailable.
TOTAL PAGES IN THIS WEBSITE
1
Send to a friend | Prevnar Adult
http://www.adult.prevnar13.com/send-to-a-friend/front/node/6
Skip to main content. Indication for Prevnar 13. Is a vaccine approved for adults 18 years of age and older for the prevention of pneumococcal pneumonia and invasive disease caused by 13. Strains (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F). Is not 100% effective and will only help protect against the 13 strains included in the vaccine. Should not be given to anyone with a history of severe allergic reaction to any component of Prevnar 13. Or any diphtheria toxoid containing vaccine. The pers...
Send to a friend | Prevnar Adult
http://www.adult.prevnar13.com/send-to-a-friend/front/node/10
Skip to main content. Indication for Prevnar 13. Is a vaccine approved for adults 18 years of age and older for the prevention of pneumococcal pneumonia and invasive disease caused by 13. Strains (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F). Is not 100% effective and will only help protect against the 13 strains included in the vaccine. Should not be given to anyone with a history of severe allergic reaction to any component of Prevnar 13. Or any diphtheria toxoid containing vaccine. The pers...
Send to a friend | Prevnar Adult
http://www.adult.prevnar13.com/send-to-a-friend/front/node/11
Skip to main content. Indication for Prevnar 13. Is a vaccine approved for adults 18 years of age and older for the prevention of pneumococcal pneumonia and invasive disease caused by 13. Strains (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F). Is not 100% effective and will only help protect against the 13 strains included in the vaccine. Should not be given to anyone with a history of severe allergic reaction to any component of Prevnar 13. Or any diphtheria toxoid containing vaccine. The pers...
TOTAL LINKS TO THIS WEBSITE
32
Prevnar.ca
Skip to main content. What is pneumococcal disease? Who is at risk? How is it transmitted? What is Prevnar 13? How does it work? Who is at risk? Immunization schedule and dosing. What is pneumococcal disease? What is Prevnar 13? How does it work? Infants, Toddlers and Young Children. Immunization schedule and dosing. What is pneumococcal disease? What is Prevnar 13? How does it work? Watch the TV ad. 6 weeks to 5 years). 6 to 17 years old). For more information, please consult your healthcare provider.
Safety Info | PREVNAR 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein])
Skip directly to content. Is a vaccine indicated in children 6 weeks through 17 years (prior to the 18th birthday) for active immunization for the prevention of invasive disease caused by. Serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F, and for children 6 weeks through 5 years of age (prior to the 6th birthday) for the prevention of otitis media caused by 7 of the 13 serotypes in the vaccine. In adults 18 years of age and older, Prevnar 13. Serotypes in the vaccine. 13 in Canada,. Sever...
Blank
INDICATIONS AND IMPORTANT SAFETY INFORMATION FOR PREVNAR 13. Indications for Prevnar 13. Is a vaccine approved for adults 50 years of age and older for the prevention of pneumococcal pneumonia and invasive disease caused by 13 Streptococcus pneumoniae. Strains (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F). This indication is based upon immune responses to the vaccine. For children 6 weeks through 17 years of age, Prevnar 13. Or any diphtheria toxoid–containing vaccine. A temporary pause of bre...
Vacuna PREVNAR 13® conjugada antineumocócica 13 valente (proteína diftérica CRM197) para adultos | Información de seguridad
Skip to main content. Indicaciones para Prevnar 13. Es una vacuna aprobada para adultos de 18 años y mayores para la prevención de la neumonía neumocócica y la enfermedad invasiva causada por 13 cepas de. 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F y 23F). No es 100% efectiva y solo ayudará a proteger contra las 13 cepas incluidas en la vacuna. INFORMACIÓN DE SEGURIDAD SELECCIONADA. No se debe dar Prevnar 13. O de cualquier vacuna que contenga el toxoide diftérico. Indicaciones para Prevnar 13. Para Pr...
Blank
Invasive pneumococcal disease vaccination for children aged. 6 weeks through 5 years. Pneumococcal pneumonia and invasive disease vaccination for adults aged 50. Para Padres (Español). Para Adultos 50 (Español). INDICATIONS FOR PREVNAR 13. Is a vaccine approved for children 6 weeks through 17 years of age for the prevention of invasive disease caused by 13. Based upon immune responses to the vaccine, Prevnar 13. Or any diphtheria toxoid containing vaccine. The most commonly reported serious adverse event...
Información sobre la ENI | PREVNAR 13® (vacuna antineumocócica conjugada 13 valente [proteína diftérica CRM197]) | Información de seguridad
Skip to main content. INDICACIÓN DE PREVNAR 13. Es una vacuna aprobada para niños de 6 semanas a 17 años de edad para la prevención de la enfermedad invasiva causada por 13 cepas de Streptococcus pneumoniae. También está aprobada para niños de 6 semanas a 5 años de edad para la prevención de la otitis media (infección del oído) causada por 7 de las 13 cepas. No es eficaz al 100% y solo ayuda a proteger frente a las 13 cepas incluidas en la vacuna. INFORMACIÓN DE SEGURIDAD SELECTA. INDICACIÓN DE PREVNAR 13.
IIS7
IPD Treatment | PREVNAR 13® Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein) Safety Info
Skip to main content. Indications for Prevnar 13. Is a vaccine approved for children 6 weeks through 17 years of age for the prevention of invasive disease caused by 13. Strains (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F), and for children 6 weeks through 5 years for the prevention of otitis media caused by 7 of the 13 strains (4, 6B, 9V, 14, 18C, 19F, and 23F). Based upon immune responses to the vaccine, Prevnar 13. Para Adultos 50 (Español). For Infants and Young Children. Is a bacterial d...
Safety Info | PREVNAR 13® Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein)
Invasive pneumococcal disease vaccination for children aged. 6 weeks through 5 years. Pneumococcal pneumonia and invasive disease vaccination for adults aged 50. Para Padres (Español). Para Adultos 50 (Español). INDICATIONS FOR PREVNAR 13. Is a vaccine approved for children 6 weeks through 17 years of age for the prevention of invasive disease caused by 13. Based upon immune responses to the vaccine, Prevnar 13. Or any diphtheria toxoid containing vaccine. The most commonly reported serious adverse event...
Safety Info | PREVNAR 13® Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein)
Invasive pneumococcal disease vaccination for children aged. 6 weeks through 5 years. Pneumococcal pneumonia and invasive disease vaccination for adults aged 50. Para Padres (Español). Para Adultos 50 (Español). INDICATIONS FOR PREVNAR 13. Is a vaccine approved for children 6 weeks through 17 years of age for the prevention of invasive disease caused by 13. Based upon immune responses to the vaccine, Prevnar 13. Or any diphtheria toxoid containing vaccine. The most commonly reported serious adverse event...
prevnarlawsuit.com - lawsuit Resources and Information.
This webpage was generated by the domain owner using Sedo Domain Parking. Disclaimer: Sedo maintains no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo nor does it constitute or imply its association, endorsement or recommendation.
